Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.

Inclusion Criteria:

• Humana Medicare Advantage member
• Type 2 diabetes diagnosis
• HbA1c levels ≥ 8.0% verified by lab test

Exclusion Criteria:

• Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease
• Not fluent in English
• Humana membership is part of a Full or Global risk arrangement
• Enrolled in Humana at Home Care Management